Accéder au contenu
Merck

RhoA Controls Axon Extension Independent of Specification in the Developing Brain.

Current biology : CB (2019-11-05)
Sebastian Dupraz, Brett J Hilton, Andreas Husch, Telma E Santos, Charlotte H Coles, Sina Stern, Cord Brakebusch, Frank Bradke
RÉSUMÉ

The specification of an axon and its subsequent outgrowth are key steps during neuronal polarization, a prerequisite to wire the brain. The Rho-guanosine triphosphatase (GTPase) RhoA is believed to be a central player in these processes. However, its physiological role has remained undefined. Here, genetic loss- and gain-of-function experiments combined with time-lapse microscopy, cell culture, and in vivo analysis show that RhoA is not involved in axon specification but confines the initiation of neuronal polarization and axon outgrowth during development. Biochemical analysis and super-resolution microscopy together with molecular and pharmacological manipulations reveal that RhoA restrains axon growth by activating myosin-II-mediated actin arc formation in the growth cone to prevent microtubules from protruding toward the leading edge. Through this mechanism, RhoA regulates the duration of axon growth and pause phases, thus controlling the tightly timed extension of developing axons. Thereby, this work unravels physiologically relevant players coordinating actin-microtubule interactions during axon growth.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Sérum de chèvre
Sigma-Aldrich
Nocodazole, ≥99% (TLC), powder
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
Latrunculin A, from sea sponge, ≥85% (HPLC), waxy solid
Sigma-Aldrich
Phalloidin–Atto 647N, BioReagent, suitable for fluorescence, ≥80% (HPLC)